Primary and secondary insomnia: Prevalence, causes and current therapeutics

Current Medicinal Chemistry - Central Nervous System Agents

Volumn 4, Issue 2, 2004, Pages 119-137

  Monti, Jaime M ^a  

^a HOSPITAL DE CLÍNICAS   (Uruguay)

Author keywords

subunit; aminobutyric acid; Benzodiazepine hypnotics; Primary insomnia; Secondary insomnia; Sleep; Zaleplon; Zolpidem; Zopiclone

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CYCLOPYRROLONE DERIVATIVE; DULOXETINE; FLUNITRAZEPAM; FLURAZEPAM; IMIDAZOPYRIDINE DERIVATIVE; IMIPRAMINE; MAPROTILINE; MIDAZOLAM; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN UPTAKE INHIBITOR; NORTRIPTYLINE; PHENELZINE; PROTRIPTYLINE; PYRAZOLOPYRIMIDINE DERIVATIVE; PYRROLE DERIVATIVE; SEROTONIN UPTAKE INHIBITOR; SHORT ACTING DRUG; TEMAZEPAM; TRANYLCYPROMINE; TRIAZOLAM; UNCLASSIFIED DRUG; UNINDEXED DRUG; VENLAFAXINE; ZALEPLON; ZOLPIDEM; ZOPICLONE;

ABDOMINAL PAIN; ANTEROGRADE AMNESIA; ASTHENIA; ATAXIA; DEPRESSION; DIZZINESS; DROWSINESS; DRUG ABUSE; DYSARTHRIA; ELDERLY CARE; FATIGUE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPNOSIS; INSOMNIA; LABORATORY DIAGNOSIS; MENOPAUSE; MENTAL DISEASE; NAUSEA; NEUROLOGIC DISEASE; NIGHTMARE; NONREM SLEEP; PREGNANCY; PREVALENCE; REBOUND; REVIEW; SIDE EFFECT; SLEEP DISORDER; SLEEP TIME; SOMNOLENCE; STATISTICAL SIGNIFICANCE; TASTE DISORDER;

EID: 2442442277     PISSN: 15680150     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568015043357039     Document Type: Review

References (198)

1. Rechtschaffen, A.; Kales, A. A Manual of Standardized Terminology Techniques and Scoring System for Sleep Stages in Human Subjects, National Institute of Health Publ. 204. U.S. Government Printing Office: Washington, D.C., 1968.
2. Webb, H.W. In Sleep Behavior as a Biorhythm; Colquehoun, W.P., Ed.; Academic Press: New York, 1971, pp. 149-177.
3. Monti, J.M. Meth. and Find Exptl. Clin. Pharmacol., 1981, 3, 303.
4. National Sleep Foundation. Sleep in America: a national survey of U.S. adults, The Gallup Organization: Princeton, 1991.
5. Ancoli-Israel, S.; Roth, T. Sleep, 1999, 22 (Suppl. 2), 347.
6. Lugaresi, E.; Cirignotta, F.; Zucconi, M.; Mondini, S.; Lenzi, P.L.; Coccagna, G. In Sleep/Wake Disorders: Natural History, Epidemiology, and Long-Term Evolution; Guilleminault, C.; Lugaresi, E., Eds.; Raven Press: New York, 1983; pp. 1-12.
7. Hohagen, F.; Rink, K.; Käppler, C.; Schramm, E.; Riemann, D.; Weyerer, S.; Berger, M. Eur. Arch. Psychiat. Clin. Neurosci., 1993, 242, 329.
8. Weyerer, S.; Dilling, H. Sleep, 1991, 14, 392.
9. Balter, M.B.; Uhlenhuth, E.H. J. Clin. Psychiat., 1992, 53 (Suppl. 12), 34.
10. Simon, G.E.; VonKorff, M. Amer. J. Psychiat., 1997, 154, 1417.
11. Shochat, T.; Umphress, J.; Israel, A.G.; Ancoli-Israel, S. Sleep, 1999, 22 (Suppl. 2), 359.
12. Foley, D.J.; Monjan, A.A.; Brown, S.L.; Simonsick, E.M.; Wallace, R.B.; Blazer, D.G. Sleep, 1995, 18, 425.
13. Cornoni-Huntley, J.C.; Ostfeld, A.M.; Taylor, J.O., Wallace, R.B.; Blazer, D.; Berkman, L.F.; Evans, D.A.; Kohout, F.J.; Lemke, J.H.; Scherr, P.A. ; Korper, S.P. Aging Clin. Exp. Res., 1993, 5, 27.
14. Foley, D.J.; Monjan, A.; Simonsick, E.M.; Wallace, R.B.; Blazer, D.G. Sleep, 1999, 22 (Suppl. 2), 366.
15. Drugs and insomnia. Consensus conference. JAMA, 1984, 251, 2410.
16. th edition. American Psychiatric Press: Washington, D.C., 1994.
17. Lichstein, K.L. In Treatment of Late-Life Isomnia, Lichstein, K.L.; Morin, C.M., Eds.; Sage Publications: Thousand Oaks. 2000, pp. 297-319.
18. American Sleep Disorders Association. International Classification of Sleep Disorders, revised: Diagnostic and Coding Manual. American Sleep Disorders Association: Rochester, 1997.
19. Bonnet, M.H.; Arand, D.L. Sleep Med. Rev., 1997, 1, 97.
20. McCrae, C.S.; Lichstein, K.L. Sleep Med. Rev. 2001, 5, 47.
21. Monti, J.M.; Monti, D. Sleep Med. Rev. 2000, 4, 263.
22. Mellman, T.A.; Uhde, T.W. Arch. Gen. Psychiatry, 1989, 46, 178.
23. Kerkhofs, M. Sleep Med. Rev. 1997, 1, 109.
24. Mellman, T.A.; Davis, C.G. J. Clin. Psychiat., 1985, 46. 379.
25. Benson, K.L.; Zarcone, V.P. In Principles and Practice of Sleep Medicine, Kryger, M.H.; Roth, T.; Dement, W.C., Eds; Saunders: Philadelphia, 2000, pp. 1159-1167.
26. Bliwise, D.L. In Principles and Practice of Sleep Medicine; Kryger, M.H. ; Roth, T.; Dement, W.C., Eds.; Saunders: Philadelphia, 2000, pp. 1058-1071.
27. Prinz, P.N.; Vitaliano, P.; Vitiello, M.V.; Bokan, J.; Raskind, M.; Perkind, E.; Gerber, C. Neurobiol. Aging, 1982, 3, 361.
28. Vitiello, M.V.; Prinz, P.N.; Williams, D.E.; Frommlet, M.S.; Ries, R.K. J. Gerontol., 1990, 45, M131.
29. McCurry, S.M.; Reynolds, C.F.; Ancoli-Israel, S.; Teri, L.; Vitiello, M.V. Sleep Med. Rev., 2000, 4, 603.
30. Partinen, M. J. Neurology, 1997, 244 (Suppl. 1), S3.
31. Tandberg, E.; Larsen, J.P.; Karlsen, K. Mov. Disorders, 1998, 13, 895.
32. Chokroverty, S. In Sleep Disorders Medicine: Basic Science, Technical Considerations, and Clinical Aspects; Chockroverty, S.; Daroff, R.B., Eds.; Butterworth: Boston, 1999, pp. 509-571.
33. Schaffer, J; Greulich, A. J. Neurol., 2000, 247 (Suppl. 4), 24.
34. Shouse, M.N.; Mahowald, M.W. In Principles and Practice of Sleep Medicine; Kryger, M.H.; Roth, T.; Dement, W.C., Eds; Saunders: Philadelphia, 2000, pp. 707-723.
35. Shouse, M.N.; da Silva, A.M.; Sammaritano, M. J. Clin. Neurophysiol., 1996, 13, 32.
36. Bassetti, C.; Chervin, R. In Principles and Practice of Sleep Medicine; Kryger, M.H.; Roth, T.; Dement, W.C., Eds.; Saunders: Philadelphia, 2000, pp. 1072-1086.
37. Deegan, P.C.; McNicholas, W.T. Eur. Respir. J., 1996, 9, 117.
38. Anch, M.; Orr, W.C.; Karacan, I. J. Human Stress, 1976, 2, 15.
39. Kaye, J.; Kaye, K.; Modow, L. J. Psychol., 1983, 114, 107.
40. Kales, A.; Beall, G.N.; Bajor, G.F.; Jacobsen, A.; Kales, J.D. J. Allergy, 1968, 41, 164.
41. McNicholas, W.T. Eur. Respirat. J., 1997, 10, 920.
42. Janson, C.; Gislason, T.; Boman, G.; Hetta, J.; Roos, B.E. Respirat. Med., 1990, 84, 37.
43. Pérez-Padilla, R.R.; West, P.; Letzman, M. Am. Rev. Respir. Dis., 1985, 132, 224.
44. Kales, A.; Heuser, G.; Jacobson, A.; Kales, J.D.; Hanley, J.; Zweizig, J.R.; Paulson, M.J. J. Clin. Endocrinol. Metab., 1967, 27, 1593.
45. Dunleavy, D.L.F.; Oswald, I.; Brown, P.; Strong, J.A. Electroenceph. Clin. Neurophysiol., 1974, 36, 259.
46. Savard, J.; Morin, C.M. J. Clin. Oncol., 2001, 19, 895.
47. Pollmächer, T.; Holsboer, F. Sleep Res. Soc. Bull., 1996, 2, 37.
48. Moldofsky, H.; Lue, F.A.; Smythe, H.A. J. Rheumatol., 1983, 10, 373.
49. Moldofsky, H.; Lue, F.A.; Saskin, P. J. Rheumatol., 1987, 14, 124.
50. Pongratz, D.E.; Sievers, M. Scand. J. Rheumatol., 2000, 29 (Suppl. 113), 3.
51. Driver, H.S.; Derk-Jan, D.; Werth, E.; Biedermann, K.; Borbély, A. J. Clin. Endocrinol. Metab., 1996, 81, 728.
52. Santiago, J.R.; Nodello, M.S.; Kinzler, W.; Santiago, T.V. Ann. Intern. Med., 2001, 134, 396.
53. Polo-Kantola, P.; Saaresranta, T.; Polo, O. CNS Drugs, 2001, 15, 445.
54. Polo-Kantola, P.; Erkkola, R.; Helenius, H.; Irjala, K.; Polo, O. Amer. J. Obstetr. Gynecol., 1998, 178, 1002.
55. Serafin, W.E. In The Pharmacological Basis of Therapeutics; Hardman, J.G.; Limbird, L.E., Eds.; McGraw-Hill: New York, 1996; pp. 659-682.
56. Kay, D.; Blackburn, A.B.; Buckingham, J.A.; Karacan, I. In Pharmacology of Sleep; Williams, R.L.; Karacan, I., Eds.; John Wiley: New York, 1976; pp. 83-210.
57. Alford, C.; Bhatti, J.; Leigh, T.; Jamieson, A.; Hindmarch, I. Human Psychopharmacol., 1996, 11, 185.
58. Fitzpatrick, M.F.; Engelman, H.M.; Boellert, F.; McHardy, R.; Shapiro, C.M., Deary, I.J.; Douglas, N.J. Amer. Rev. Respirat. Dis., 1992, 145, 1355.
59. Kaplan, J.; Fredrickson, P.A.; Renaux, S.A.; O'Brien, P.C. Chest, 1993, 103, 193.
60. Soldatos, C.R.; Kales, J.D.; Scharf, M.B.; Bixler, E.O.; Kales, A. Science, 1980, 207, 551.
61. Gillin J.C.; Lardon, M.; Ruiz, C.; Golshan, S.; Salin-Pascual, R. J. Clin. Psychopharmacol., 1994, 14, 264.
62. Declerck, A.C.; Wauquier, A. Epilepsy Res., 1991, 199 (Suppl. 2), 153.
63. Roder-Wanner, U.U.; Nochtar, S.; Wolf, P. Acta Neurol. Scand, 1988, 76, 157.
64. Sadler, M. Epilepsia, 1999, 40, 322.
65. Placidi, F.; Diomedi, M., Scalise, A.; Marciani, M.G.; Romigi, A.; Gigli, G.L. Neurology, 2000, 54 (Suppl. 1), 25.
66. Monti, J.M. Life Sci., 1987, 41, 1979.
67. Pellejero, T.; Monti, J.M.; Baglietto, J.; Jantos, H.; Pazos, S.; Cichevski, V.; Hawkins, M. Sleep, 1984, 7, 365.
68. Leonetti, G.; Salvetti, A. J. Cardiovasc. Pharmacol., 1994, 24 (Suppl. 3), 73.
69. Nicholson, A.N.; Wright, N.A.; Zetlein, M.B.; Currie, D.; McDevitt, D.G. Br. J. Clin. Pharmacol., 1990, 30, 537.
70. Ebert, U.; Kirch, W. Eur. J. Clin. Pharmacol., 1999, 55, 255.
71. Moser, N.J.; Phillips, B.A.; Guthrie, G.; Barnett, G. Pharmacol. Toxicol., 1996, 78, 100.
72. Pace-Schott, E.F.; Hobson, J.A. In Neuropsychopharmacology - The Fifth Generation of Progress; Davis, K.L.; Charney, D.; Coyle, J.T.; Nemeroff, C., Eds.; Lippincott Williams & Wilkins: Philadelphia, 2002, pp. 1859-1877.
73. Zoltoski, R.K.; Cabeza, R.J.; Gillin, J.C. In Sleep Disorders Medicine; BasicScience, Technical Considerations, and Clinical Aspects; Chokroverty, S.; Daroff, R.B., Eds.; Butterworth-Heinemann: Boston, 1999, pp. 63-94.
74. Baghdoyan, H.A.; Lydic, R. In Sleep and Epilepsy: The Clinical Spectrum; Bazil, C.W.; Malow, B.A.; Sammaritano, M.R., Eds.; Elsevier Science B. V.: Amsterdam, 2002, pp. 17-44.
75. Jones, B.A. In Principles and Practice of Sleep Medicine; Kryger, M.H.; Roth, T.; Dement, W.C., Eds.; W.B. Saunders: Philadelphia, 2000, pp. 134-154.
76. Saper, C.B.; Sherin, J.E.; Elmquist, J.K. In Sleep and Sleep Disorders: From Molecule to Behavior; Hayaishi, O.; Inoue, S., Eds.; Academic Press: Tokyo, 1997, pp. 281-294.
77. Sterman, M.B.; Clemente, C.D. Exp. Neurol., 1962, 6, 103.
78. Lucas, E.A.; Sterman, M.B. Exp. Neurol. 1975, 46, 368.
79. Alam, M.N.; McGinty, D.; Szymusiak, R. Am. J. Physiol. 1995, 38, 1240.
80. Alam, M.N.; McGinty, D.; Szymusiak, R. Brain Res. 1997, 752, 81.
81. Szymusiak, R.; Steininger, T.; Alam, N.; McGinty, D. Arch. Ital. Biol., 2001, 139, 77.
82. Alam, M.N.; Szymusiak, R.; Gong, H.; King, J.; McGinty, D. J. Physiol., 1999, 521, 679.
83. Strecker, R.E.; Morairty, S.; Thakkar, M.M.; Porkka-Heiskanen, T.; Basheer, R.; Dauphin, L.J.; Rainnie, D.G.; Portas, C.M.; Greene, R.W.; McCarley, R.W. Behav. Brain Res., 2000, 115, 183.
84. Portas, C.M.; Thakkar, M.; Rainnie, D.G.; Greene, R.W.; McCarley, R.W. Neuroscience, 1997, 79, 225.
85. Mallick, B.N.; Majumdar, S.; Faisal, M.; Yadav, V.; Madan, V.; Pal, D. J. Biosci., 2002, 27, 539.
86. Misgeld, U.; Bijak, M.; Jarolimek, W. Prog. Neurobiol., 1995, 46, 423.
87. Haefely, W.E. In The Challenge of Neuropharmacology; Mohler, H.C.; Da Prada, M., Eds.; Editiones Roche: Basel, 1994, pp. 15-39.
88. Paul, S.M. In Psychopharmacology: The Fourth Generation of Progress; Bloom, F.E.; Kupfer, D.J., Eds.; Raven Press: New York, 1995, pp. 87-94.
89. Graham, D.; Besnard, F.; Faure, C.; Langer S.Z. Sleep, 1996, 19, S43.
90. Teuber, L.; Wätjen, F.; Jansen, L.H. Curr. Pharmaceut. Des., 1999, 5, 317.
91. Mohler, H.; Okada, T. Science, 1977, 198, 849.
92. Squires, R.F.; Braestrup, C. Nature, 1977, 266, 732.
93. Gunther, U.; Benson, J.; Benke, D.; Fritschy, J.M.; Reyes, G.; Knoflach, F.; Crestani, F.; Aguzzi, A.; Arigoni, M.; Lang. Y. Proc. Natl. Acad. Sci. USA, 1995, 92, 7749.
94. Rudolph, U.; Crestani, F.; Benke, D.; Brunig, I.; Benson, J.A.; Fritschy, J.M.; Martin, J.R.; Bluethmann, H.; Mohler, H. Nature, 1999, 401, 796.
95. Löw, K.; Crestani, F.; Keist, R.; Benke, D.; Brunig, I.; Benson, J.A.; Fritschy, J.M.; Rulicke, T.; Bluethmann, H.; Mohler, H.; Rudolph, U. Science, 2000, 290, 131.
96. Dämgen, K.; Lüddens, H. Neurosci. Res. Commun., 1999, 25, 139.
97. Harvey, S.C. In The Pharmacological Basis of Therapeutics, Goodman, L.S. ; Gilman, A. Eds.; MacMillan: New York, 1975, pp. 102-123.
98. Mohler, H. Drug. Res., 1992, 42, 211.
99. Garzone, P.D.; Kroboth, P.D. Clin. Pharmacokinet., 1989, 16, 337.
100. Greenblatt, D.J.; Harmatz, J.S.; Engelhardt, N.; Shader, R.I. Arch. Gen. Psychiatry, 1989, 46, 326.
101. Musch, B.; Maillard, F. Int. Clin. Psychopharmacol., 1990, 5 (Suppl. 2), 147.
102. Thenot, J.P.; Hermann, P.; Durand, A.; Burke, J.T.; Allen, J.; Garrigou, D.; Vajta, S.; Albin, H.; Thebault, J.J.; Olive, G.; Warrington, S.J. In Imidazopyridines in Sleep Disorders; Sauvanet, J.P.; Langer, S.Z.; Morselli, P.L., Eds.; Raven Press: New York, 1988, pp. 139-153.
103. Hurst, M.; Noble, S. CNS Drugs, 1999, 11, 387.
104. Rosen, A.S.; Fournie, P.; Darwish, M.; Danjou, P.; Troy, S.M. Biopharm. Drug Disposition, 1999, 20, 171.
105. Kales, A.; Kales, J.D. Evaluation and Treatment of Insomnia, Oxford University Press: New York, 1984.
106. Monti, J.M.; Alterwain, P. Drug. Res., 1987, 21, 479.
107. Mitler, M.M.; Seidel, B.A.; van den Hoed, J.; Greenblatt, D.J.; Dement, W.C. J. Clin. Psychopharmacol., 1984, 4, 2.
108. Monti, J.M.; Attali, P.; Monti, D.; Zipfel, A.; de la Giclais, B.; Morselli, P.L. Pharmacopsychiatry, 1994, 27, 166.
109. Kales, A.; Bixler, E.O.; Soldatos, C.R.; Vela-Bueno, A.; Jacoby, J.; Kales, J.D. Clin. Pharmacol. Ther., 1982, 32, 781.
110. Bixler, E.O.; Kales, A.; Soldatos, C.R.; Scharf, M.B.; Kales, J.D. J Clin. Pharmacol., 1978, 18, 110.
111. Mamelak, M.; Csima, A.; Price, V. J. Clin. Pharmacol., 1984, 24, 65.
112. Kales, A.; Bixler, E.O.; Soldatos, C.R.; Vela-Bueno, A.; Jacoby, J.A.; Kales, J.D. Clin. Pharmacol. Ther., 1986, 39, 345.
113. Vgontzas, A.; Kales, A.; Bixler, E.O.; Myers, D.C. Eur. J. Clin. Pharmacol., 1994, 46, 209.
114. Soldatos, C.R.; Dikeos, D.G.; Whitehead, A. Int. Clin. Psychopharmacol., 1999, 14, 287.
115. Mamelak, M.; Scima, A.; Price, V. Pharmacology, 1983, 27 (Suppl. 2), 136.
116. Quadens, O.P.; Hoffman, G.; Buytaert, G. Pharmacology, 1983, 27 (Suppl. 2),146.
117. Pecknold, J.; Wilson, R.; Le Morvan, P. Int. Clin. Psychopharmacol., 1990, 5 (Suppl. 2), 57.
118. Billiard, M.; Besset, A.; De Lustrac, C.; Brissaud, L.; Cadilhac, J. Neurophysiol. Clin., 1989, 19, 131.
119. Tiberge, M.; Calvet, U.; Khayi, N.; Delahye, C.; Arbus, L. Encephale, 1988, 14, 319.
120. Jovanovic, U.J.; Dreyfus, J.F. Pharmacology, 1983, 27 (Suppl. 2), 136.
121. Noble, S.; Langtry, H.D., Lamb, H.M. Drugs, 1998, 55, 277.
122. Nicholson, A.N.; Pascoe, P.A. Br. J. Clin. Pharmacol., 1986, 21, 205.
123. Herrmann, W.M.; Dubicki, S.; Wober, W. In Imidazopyridines in Sleep Disorders, Sauvanet, J.P.; Langer, S.Z.; Morselli, P.L., Eds.; Raven Press: New York, 1988, 261-278.
124. Monti, J.M. Eur. J. Clin. Pharmacol., 1989, 36, 461.
125. Monti, J.M.; Monti, D.; Estevez, F.; Giusti, M. Int. Clin. Psychopharmacol., 1996, 11, 255.
126. Okuma, T.; Monti, J.M. In Zolpidem: An Update of its Pharmacological Properties and Therapeutic Place in the Management of Insomnia; Freeman, H.; Puech, A.J.; Roth, T., Eds.; Elsevier: Paris, 1996, pp. 117-127.
127. Benoit, O.; Bouard, G.; Payan, C.; Prado, J.; Blanchet, G. Psychopharmacology, 1994, 116, 297.
128. Monti, J.M.; Alvariño, F.; Monti, D. Sleep, 2000, 23, 1075.
129. Roger, M.; Dallot, J.Y.; Salmon, O.; Neveux, E.; Gitton, J.P.; Gerson, M.; Brossel, S.; Sauvanet, J.P. In Imidazopyridines in Sleep Disorders; Sauvanet, J.P.; Langer, S.Z.; Morselli, P.L., Eds.; Raven Press: New York, 1988, pp. 279-287.
130. Sauvanet, J.P.; Maarek, L.; Roger, M.; Renaudin, J.; Louvel, E.; Orofiamma, B. In Imidazipyridines in Sleep Disorders; Sauvanet, J.P.; Langer, S.Z.; Moreselli, P.L., Eds.; Raven Press: New York, 1988, pp. 339-349.
131. Scharf, M.B.; Mendels, J.; Thorpy, M. Curr. Ther. Res., 1994, 55, 1100.
132. Heydorn, W.E. Exp. Opin. Invest. Drugs, 2000, 9, 841.
133. Walsh, J.K.; Vogel, G.W.; Scharf, M.; Erman, M.; Erwin, C.W.; Schweitzer, P.K.; Mangano, R.M.; Roth, T. Sleep Med., 2000, 1, 41.
134. Elie, R.; Ruther, E.; Farr, I.; Emilien, G.; Salinas, E. J. Clin. Psychiat., 1999, 60, 536.
135. Kales, A.; Bixler, E.O.; Scharf, M.B.; Kales, J.D. Clin. Pharmacol. Ther., 1976, 19, 576.
136. Kales, A.; Bixler, E.O.; Soldatos, C.R.; Mitsky, D.J.; Kales, J.D. J. Clin. Pharmacol., 1982, 22, 520.
137. Kales, A.; Scharf, M.B.; Soldatos, C.R.; Bixler, E.; Bianchi, S.; Schweitzer, P.K. J. Clin. Pharmacol., 1980, 20, 184.
138. Dikeos, D.G.; Soldatos, C.R. J. Clin. Psychiat., 2002, 4 (Suppl. 1), 27.
139. Bixler, E.O.; Kales, A.; Soldatos, C.R.; Scharf, M.B.; Kales, J.D. J. Clin. Pharmacol., 1978, 18, 110.
140. Scharf, M.B.; Bixler, E.O.; Kales, A.; Soldatos, C.R. Pharmacology, 1979, 19, 173.
141. Kales, A.; Kales, J.D. J. Clin. Psychopharmacol., 1983, 3, 140.
142. Lader, M.; Lawson, C. Clin. Neuropharmacol., 1987, 10, 291.
143. Monti, J.; Debellis, J.; Gratadoux, E.; Alterwain, P.; Altier, H.; D'Angelo, L. Eur. J. Clin. Pharmacol., 1982, 21, 479.
144. Scharf, M.B.; Sachais, B.A.; Mayleben, D.W.; Jennings, S.W. Curr. Ther. Res., 1990, 48, 516.
145. Monti, J.; Trenchi, H.M.; Morales, F.; Monti, L. Psychopharmacologia, 1974, 35, 371.
146. Cerone, G.; Cirignotta, R.; Coccagna, G.; Milone, F.; Lion, P.; Lorizio, A.; Lugaresi, E.; Mantovani, M.; Muratorio, A.; Murri, L.; Mutani, R.; Riccio, A. Eur. Neurol., 1974, 11, 172.
147. Jovanovic, U.J. J. Int. Med. Res., 1977, 5, 77.
148. Lader, M. Psychopharmacology, 1992, 108, 248.
149. Maggioni M.; Frattola, L. In Imidazopyridines in Sleep Disorders: A Novel Experimental Approach; Sauvanet, J.P.; Langer, S.Z.; Morselli, P.L., Eds. ; Raven Press: New York, 1988; pp. 386-387.
150. Shaw, S.H. In Imidazopyridines in Sleep Disorders: A Novel Experimental Approach; Sauvanet, J.P.; Langer, S.Z.; Morselli, P.L., Eds.; Raven Press: New York, 1988; p. 389.
151. Lorizio, A.; Terzano, M.G.; Parrino, L.; Cesana, B.M.; Priore, P. Cur. Ther. Res., 1990, 47, 889.
152. Schlich, D.; L'Heritier, C.; Coquelin, J.P.; Attali, P. J. Int. Med. Res., 1991, 19, 271.
153. Kryger, M.H.; Steljes, D.; Pouliot, Z.; Neufeld, H.; Odynski, T. Sleep, 1991, 14, 399.
154. Allain, H.; Monti, J. Eur. Psychiatry, 1997, 12 (Suppl. 1), 21S-29S.
155. Walsh, J.K.; Fry, J.; Erwin, C. Scharf, M.; Roth, T.; Vogel, G. Clin. Drug. Investigations, 1998, 16, 347.
156. Ancoli-Israel, S., Walsh, J.K.; Mangano, R.M.; Fujimori, M. J. Clin. Psychiat., 1999, 1, 114.
157. Fry, J.; Scharf, M.; Mangano, R.M., Fujimori, M. Int. Clin. Psychopharmacol., 2000, 15, 141.
158. Greenblatt, D.J.; Divoll, M.; Darrell, R.; Shader, R.I. Drug Metab. Rev., 1983, 14, 251.
159. Bixler, E.O.; Scharf, M.B.; Soldatos, C.R.; Mitsky, D.J.; Kales, A. Life Sci., 1979, 25, 1379.
160. Bixler, E.O.; Kales, A.; Manfredi, R.L.; Vgontzas, A.N.; Tyson, K.L.; Kales, J.D. Lancet, 1991, 337, 827.
161. Curran, V.H.; Birch, B. Psychopharmacology, 1991, 103, 519.
162. Hindmarch, I.; Haller, J.; Sherwood, N.; Kerr, J.S. Neuropsychobiology, 1990, 91, 84.
163. Oswald, I.; Adam, K. Pharmacopsychiatry, 1989, 22, 115.
164. Lader, M. CNS Drugs, 1994, 1, 377.
165. Ray, W.A.; Griffin, M.R. Top. Geriatr. Rehabil., 1990, 5, 12.
166. Trewin, V.F.; Lawrence, C.J.; Veitch, G.B.A. J. Clin. Pharm. Ther., 1992, 17, 129.
167. Allain, H.; Delahaye, C.; Le Coz, F.; Blin, P.; Decombe, R.; Martinet, J.P. Sleep, 1991, 14, 407.
168. Kuitunen, T.; Mattila, M.J.; Seppala, T. Int. J. Psychopharmacol., 1990, 5 (Suppl. 2), 115.
169. Holm, K.J.; Goa, K.L. Drugs, 2000, 59, 865.
170. Kupfer, D.J. Ann. Clin. Psychiatr., 1999, 11, 267.
171. Monti, J.M.; Monti, D. Life Sci., 2000, 66, 1999.
172. Oberndorfer, S.; Saletu-Zyhlarz, G.; Saletu, B. Pharmacopsychiatry, 2000, 42, 69.
173. Luthringer, R.; Toussaint, M.; Schaltenbrand, N.; Bailey, P.; Danjou P.H.; Hachett, D.; Guichoux, J.Y.; Macher, J.P. Psychopharmacol. Bull., 1996, 32, 637.
174. Monti, J.M.; Alterwain, P.; Monti, D. J. Affect. Disord., 1990, 20, 201.
175. Nofzinger, E.A., Reynolds, C.F.; Thase, M.E.; Frank, E.; Jennings, J.R.; Fasiczka, A.L.; Sullivan, L.R.; Kupfer, D.J. Amer. J. Psychiat., 1995, 152, 274.
176. Nofzinger, E.A.; Fasiczka, A.; Berman, S.; Thase, M.E. J. Clin. Psychiat., 2000, 61, 858.
177. Monti, J.M.; Monti, D. CNS Drugs, 2000, 13, 87.
178. Monti, J.M.; Cardinali, D.P. Biol. Signals Recept., 2000, 9, 328.
179. Hughes, J.M.; Sack, R.L.; Lewy, A.J. Sleep, 1998, 21, 52.
180. Monti, J.M.; Alvariño, F.; Cardinali, D.; Savio, I.; Pintos, A. Arch. Gerontol. Geriatrics, 1999, 28, 85.
181. Haimov, I.; Lavie, P. Drugs Aging, 1995, 7, 75
182. MacFarlane, J.G.; Cleghorn, J.M.; Brown, G.M.; Streiner, D.L. Biol. Psychiatry, 1991, 30, 371.
183. Fainstein, I.; Bonetto, A.; Brusco, L.I.; Cardinali, D.P. Curr. Ther. Res., 1997, 58, 990.
184. Brusco, L.I.; Fainstein, I.; Marquez, M.; Cardinali, D.P. Biol. Signals Recept., 1999, 8, 126.
185. Goldbeck-Wood, S.; Dorozynski, A.; Lie, L. Br. Med. J., 1996, 313, 131.
186. Leathwood, P.D.; Chauffard, F. J. Psychiatr. Res., 1983, 17, 115.
187. Baldener, G.; Borbely, A.A. Psychopharmacology, 1985, 87, 406.
188. Vorbach, E.V.; Gortelmayer, R.; Bruning, J. Pharmakotherapie, 1996, 3, 109.
189. Volz, H.P.; Kieser, M. Pharmacopsychiatry, 1997, 30, 1.
190. Emser, W.; Bartylla, K. Neurologie/Psychiatrie, 1991, 5, 636.
191. Bootzin, R.R.; Epstein, D.R. In Treatment of Late-Life Insomnia; Lichstein, K.L.; Morin, C.M., Eds.; Sage Publications: London, 2000, pp. 167-184.
192. Wohlgemuth, W.K.; Edinger, J.D. In Treatment of Late-Life Insomnia; Lichstein, K.L.; Morin, C.M., Eds.; Sage Publications: London, 2000, pp. 147-166.
193. Shapiro C.M.; MacFarlane, J.G.; Hussain M.R.G. Conquering Insomnia. Empowering Press: Hamilton, 1994.
194. Beck, A.T.; Emery, G. Anxiety Disorders and Phobias: A Cognitive Perspective. Basic Books: New York, 1985.
195. Morin, C.M.; Savard, J.; Blais, F.C. In Treatment of Late-Life Insomnia; Lichstein, K.L.; Morin, C.M., Eds.; Sage Publications: London, 2000, pp. 207-230
196. Morin, C.M.; Hauri, P.J.; Espie, C.A.; Spielman, A.J.; Buysse, D.J.; Bootzin, R.R. Sleep, 1999, 22, 1134.
197. Morin, C.M.; Stone, J.; McDonald, K. Behav. Ther., 1994, 25, 291.
198. Nowell, P.D.; Mazumdar, S.; Buysse, D.J.; Dew, M.A.; Reynolds, C.F.; Kupfer, D.J. JAMA, 1997, 278, 2170.